Home > Market Research > Prescription Medicines > The Pharmaceutical Market: Croatia

Table of Contents

Management Report
Published: January 2010
Pages: 28
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00   Buy Now!
Research from: Espicom
Sector: Prescription Medicines

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

The Republic of Croatia is located in south-eastern Europe and is bordered by Slovenia, Hungary, Serbia, Bosnia-Herzegovina and Montenegro. The population stands at an estimated 4.5 million in 2010, of whom 18.0% are aged 65 or over. Croatia is on track for EU accession by 2011 following the arrest of the war crimes suspect General Ante Gotovina. The government is aiming to bring the performance of the healthcare system into line with that of other EU member states through the National Health Strategy 2006-2011.

Around 69% of the pharmaceutical market is supplied by imports. Germany and Slovenia were the leading suppliers in 2007, accounting for over 30% of imports; countries from the EU-27 were the suppliers of 81% of all imports. The value of imports increased by over 16% in 2007.

Domestic production is dominated by Pliva, which was acquired by the US company, Barr Pharmaceuticals, in October 2006. The combination of Barr and Pliva creates the third largest global generic pharmaceutical company, in terms of revenue. In 2007, Teva acquired Barr Pharmaceuticals and thus Pliva became part of the Teva Group. Pliva reported annual sales of US$1.1 billion in year ending December 2007.

Highly detailed report content

MARKET OUTLOOK
Key national data projections

Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development

Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property

Pharmaceutical distribution

Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel

Top of Page

Table of Contents

EXECUTIVE SUMMARY 1
Introduction 2
Pharmaceutical Market Analysis . 3
Size . 3
Market Structure . 3
Generics sector . 3
Projections & Outlook . 4
Imports 7
Domestic Manufacturing . 9
Local Manufacturers 9
Pliva . 9
Belupo . 9
Exports 10
Research & Development . 11
Pharmaceutical Regulatory Analysis 12
Pharmaceutical Regulation . 12
Croatian Chamber of Pharmacists . 12
Pharmaceutical Registration . 13
Pricing & Reimbursement . 14
Intellectual Property 15
Pharmaceutical Distribution 15
Wholesaling 15
Healthcare Analysis 16
Demographics . 16
Population . 16
Birth Rate . 16
Death Rate 16
Infant Mortality . 17
Life Expectancy at Birth . 17
Public Health . 17
Causes of Death 17
Incidence of Notifiable Diseases 17
HIV/AIDS . 17
Healthcare System 18
Sustainable Health System Project 18
National Health Strategy 2006-2011 19
CROATIA PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
ii Quarter I 2010
Health Expenditure . 19
Healthcare Infrastructure 20
Inpatient Analysis 20
Healthcare Personnel . 21
DIRECTORY 22
Healthcare Organisations . 22
Trade Associations/Organisations . 22
Methodology & Sources . 24
List of Tables
Summary of Key Data Projections, 2010-2015 . 2
Summary of the Croatia Pharmaceutical Market, 2010 . 3
Projected Pharmaceutical Market, 2010-2015 4
Espicom Analysis of the Croatian Healthcare Sector . 5
SWOT Analysis of the Croatia Pharmaceutical Market . 6
Imports of Pharmaceuticals, 2003-2007 (US$000s) . 7
Import Trends (US$000s) . 7
Leading Suppliers, 2007 (US$000s). 7
Leading Suppliers of Raw Materials, 2007 (US$000s) . 8
Leading Suppliers of Retail Medicaments, 2007 (US$000s) 8
Exports of Pharmaceuticals, 2003-2007 (US$000s) . 10
Export Trends (US$000s) . 10
Leading Destinations, 2007 (US$000s) . 10
Leading Destinations of Raw Materials, 2007 (US$000s) 11
Leading Destinations of Medicaments, 2007 (US$000s) . 11
Summary of Demographic Data, 2006-2010 . 16
Projected Population, 2010-2015 . 16
Projected Health Expenditure, 2010-2015 . 19
Spending Under the Health Insurance System, 2002-2006 (HRK Millions) 20
Hospital Inpatient Activity, 1997-2007 . 20
Healthcare Personnel, 2001-2007 21
Projected Number of Physicians, 2010-2015 21

For full details, please email keithw@cmsinfo.com

Top of Page

Buy now!

PDF single user

 GBP 595.00   

Paper

 GBP 595.00   

Online Access

 GBP 595.00   

Your personal guarantee

Top of Page